Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam

被引：0
|
作者：
Alberto Hernández-Tejedor
Carmen Débora Merino-Vega
Alfredo Martín-Vivas
Rafael Ruiz de Luna-González
Alberto Delgado-Iribarren
Ángeles Gabán-Díez
Ignacio Temprano-Gómez
Natalia de la Calle-Pedrosa
Ana Isabel González-Jiménez
Alejandro Algora-Weber
机构：
[1] Hospital Universitario Fundación Alcorcón,Unidad de Cuidados Críticos
[2] Hospital Universitario Fundación Alcorcón,Unidad de Microbiología
来源：
Infection | 2017年 / 45卷
关键词：
Ceftolozane/tazobactam; Multidrug-resistant ; Bacteremia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 117
页数：2
相关论文
共 50 条
  • [41] Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin
    Schina, M
    Spyridi, E
    Daoudakis, M
    Mertzanos, E
    Korfias, S
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 (02) : 178 - 179
  • [42] Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections
    Escola-Verge, Laura
    Pigrau, Carles
    Los-Arcos, Ibai
    Arevalo, Angel
    Vinado, Belen
    Campany, David
    Larrosa, Nieves
    Nuvials, Xavier
    Ferrer, Ricard
    Len, Oscar
    Almirante, Benito
    INFECTION, 2018, 46 (04) : 461 - 468
  • [43] Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections
    Laura Escolà-Vergé
    Carles Pigrau
    Ibai Los-Arcos
    Ángel Arévalo
    Belen Viñado
    David Campany
    Nieves Larrosa
    Xavier Nuvials
    Ricard Ferrer
    Oscar Len
    Benito Almirante
    Infection, 2018, 46 : 461 - 468
  • [44] Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam
    Xipell, Marc
    Bodro, Marta
    Marco, Francesc
    Martinez, Jose A.
    Soriano, Alex
    FUTURE MICROBIOLOGY, 2017, 12 (14) : 1323 - 1326
  • [45] Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients
    Morgan Hakki
    James S. Lewis
    Infection, 2018, 46 : 431 - 434
  • [46] Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa
    Sabuda, Deana M.
    Laupland, Kevin
    Pitout, Johann
    Dalton, Bruce
    Rabin, Harvey
    Louie, Thomas
    Conly, John
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2008, 19 (06): : 413 - 418
  • [47] In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020
    Karlowsky, James A.
    Lob, Sibylle H.
    Siddiqui, Fakhar
    Akrich, Brune
    DeRyke, C. Andrew
    Young, Katherine
    Motyl, Mary R.
    Hawser, Stephen P.
    Sahm, Daniel F.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (05)
  • [48] Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients
    Hakki, Morgan
    Lewis, James S., II
    INFECTION, 2018, 46 (03) : 431 - 434
  • [49] Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary
    O'Neall, Dustin
    Juhasz, Emese
    Toth, Akos
    Urban, Edit
    Szabo, Judit
    Melegh, Szilvia
    Katona, Katalin
    Kristof, Katalin
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2020, 67 (01) : 61 - 65
  • [50] Ceftolozane/tazobactam resistance in Pseudomonas aeruginosa
    Skoglund, Erik
    Abodakpi, Henrietta
    Diaz, Lorena
    Rios, Rafael
    Tran, Truc T.
    Arias, Cesar A.
    Tam, Vincent H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S39 - S39
12345